Article Information
PubMed
Print ISSN
Online ISSN
History
- Received February 27, 2012
- Accepted April 3, 2012
- Published online June 20, 2012.
Article Versions
- Earlier version (April 4, 2012 - 06:15).
- You are viewing the most recent version of this article.
Copyright & Usage
Copyright © 2012 by The American Society for Pharmacology and Experimental Therapeutics
Author Information
- Anne-Charlotte Dubbelman,
- Robert S. Jansen,
- Hilde Rosing,
- Mona Darwish,
- Edward Hellriegel,
- Philmore Robertson Jr.,
- Jan H. M. Schellens and
- Jos H. Beijnen
- Department of Clinical Pharmacology, The Netherlands Cancer Institute, Amsterdam, The Netherlands (A.-C.D., J.H.M.S.); Department of Pharmacy and Pharmacology, Slotervaart Hospital/The Netherlands Cancer Institute, Amsterdam, The Netherlands (A.-C.D., R.S.J., H.R., J.H.B.); Clinical Pharmacology, Teva Pharmaceutical Industries Ltd., Frazer, Pennsylvania (M.D.); Nonclinical DMPK, Teva Pharmaceutical Industries Ltd., West Chester, Pennsylvania (E.H., P.R.); and Department of Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands (J.H.M.S., J.H.B.)
- Address correspondence to:
Anne-Charlotte Dubbelman, Department of Pharmacy and Pharmacology, Slotervaart Hospital/The Netherlands Cancer Institute, Louwesweg 6, 1066 EC Amsterdam, The Netherlands. E-mail: anne-charlotte.dubbelman{at}slz.nl